Andrea Kuendgen

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text

Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes

Luca Malcovati, Ulrich Germing, Andrea Kuendgen et al. · Journal of Clinical Oncology · 2007 · 1K citations

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

Andrea Kuendgen, Corinna Strupp, Manuel Aivado et al. · Blood · 2004 · 256 citations · Full text

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Michael Lübbert, Björn Rüter, Rainer Claus et al. · Haematologica · 2011 · 230 citations · Full text

The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia

Andrea Kuendgen, Mathias Schmid, Richard F. Schlenk et al. · Cancer · 2005 · 223 citations · Full text